The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Felodipine Tablets Market Research Report 2025
Synopsis
Felodipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. Felodipine relaxes blood vessels and increases the supply of blood and oxygen to the heart, which reduces the workload.
The global Felodipine Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Felodipine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Felodipine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Felodipine Tablets include Astrazeneca, Sandoz, SHANXI KANGBO BIOLOGICAL PRODUCT, Changzhou Siyao Pharmaceutical, Lianhuan Pharma, Sihuan Pharma, CR Double Crane and Xiehe Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Felodipine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Tablets.
Report Scope
The Felodipine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Felodipine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Felodipine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astrazeneca
Sandoz
SHANXI KANGBO BIOLOGICAL PRODUCT
Changzhou Siyao Pharmaceutical
Lianhuan Pharma
Sihuan Pharma
CR Double Crane
Xiehe Pharma
Segment by Type
Ordinary Tablet
Sustained Release Tablet
Segment by Application
Treat High Blood Pressure
Relieve Angina
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Felodipine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Felodipine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Felodipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. Felodipine relaxes blood vessels and increases the supply of blood and oxygen to the heart, which reduces the workload.
The global Felodipine Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Felodipine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Felodipine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Felodipine Tablets include Astrazeneca, Sandoz, SHANXI KANGBO BIOLOGICAL PRODUCT, Changzhou Siyao Pharmaceutical, Lianhuan Pharma, Sihuan Pharma, CR Double Crane and Xiehe Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Felodipine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Tablets.
Report Scope
The Felodipine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Felodipine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Felodipine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astrazeneca
Sandoz
SHANXI KANGBO BIOLOGICAL PRODUCT
Changzhou Siyao Pharmaceutical
Lianhuan Pharma
Sihuan Pharma
CR Double Crane
Xiehe Pharma
Segment by Type
Ordinary Tablet
Sustained Release Tablet
Segment by Application
Treat High Blood Pressure
Relieve Angina
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Felodipine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Felodipine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Felodipine Tablets Market Overview
1.1 Product Overview and Scope of Felodipine Tablets
1.2 Felodipine Tablets Segment by Type
1.2.1 Global Felodipine Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Ordinary Tablet
1.2.3 Sustained Release Tablet
1.3 Felodipine Tablets Segment by Application
1.3.1 Global Felodipine Tablets Market Value by Application: (2024-2030)
1.3.2 Treat High Blood Pressure
1.3.3 Relieve Angina
1.3.4 Others
1.4 Global Felodipine Tablets Market Size Estimates and Forecasts
1.4.1 Global Felodipine Tablets Revenue 2019-2030
1.4.2 Global Felodipine Tablets Sales 2019-2030
1.4.3 Global Felodipine Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Felodipine Tablets Market Competition by Manufacturers
2.1 Global Felodipine Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Felodipine Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Felodipine Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Felodipine Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Felodipine Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Felodipine Tablets, Product Type & Application
2.7 Felodipine Tablets Market Competitive Situation and Trends
2.7.1 Felodipine Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Felodipine Tablets Players Market Share by Revenue
2.7.3 Global Felodipine Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Felodipine Tablets Retrospective Market Scenario by Region
3.1 Global Felodipine Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Felodipine Tablets Global Felodipine Tablets Sales by Region: 2019-2030
3.2.1 Global Felodipine Tablets Sales by Region: 2019-2024
3.2.2 Global Felodipine Tablets Sales by Region: 2025-2030
3.3 Global Felodipine Tablets Global Felodipine Tablets Revenue by Region: 2019-2030
3.3.1 Global Felodipine Tablets Revenue by Region: 2019-2024
3.3.2 Global Felodipine Tablets Revenue by Region: 2025-2030
3.4 North America Felodipine Tablets Market Facts & Figures by Country
3.4.1 North America Felodipine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Felodipine Tablets Sales by Country (2019-2030)
3.4.3 North America Felodipine Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Felodipine Tablets Market Facts & Figures by Country
3.5.1 Europe Felodipine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Felodipine Tablets Sales by Country (2019-2030)
3.5.3 Europe Felodipine Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Felodipine Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Felodipine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Felodipine Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Felodipine Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Felodipine Tablets Market Facts & Figures by Country
3.7.1 Latin America Felodipine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Felodipine Tablets Sales by Country (2019-2030)
3.7.3 Latin America Felodipine Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Felodipine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Felodipine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Felodipine Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Felodipine Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Felodipine Tablets Sales by Type (2019-2030)
4.1.1 Global Felodipine Tablets Sales by Type (2019-2024)
4.1.2 Global Felodipine Tablets Sales by Type (2025-2030)
4.1.3 Global Felodipine Tablets Sales Market Share by Type (2019-2030)
4.2 Global Felodipine Tablets Revenue by Type (2019-2030)
4.2.1 Global Felodipine Tablets Revenue by Type (2019-2024)
4.2.2 Global Felodipine Tablets Revenue by Type (2025-2030)
4.2.3 Global Felodipine Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Felodipine Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Felodipine Tablets Sales by Application (2019-2030)
5.1.1 Global Felodipine Tablets Sales by Application (2019-2024)
5.1.2 Global Felodipine Tablets Sales by Application (2025-2030)
5.1.3 Global Felodipine Tablets Sales Market Share by Application (2019-2030)
5.2 Global Felodipine Tablets Revenue by Application (2019-2030)
5.2.1 Global Felodipine Tablets Revenue by Application (2019-2024)
5.2.2 Global Felodipine Tablets Revenue by Application (2025-2030)
5.2.3 Global Felodipine Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Felodipine Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astrazeneca
6.1.1 Astrazeneca Corporation Information
6.1.2 Astrazeneca Description and Business Overview
6.1.3 Astrazeneca Felodipine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astrazeneca Felodipine Tablets Product Portfolio
6.1.5 Astrazeneca Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Corporation Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Felodipine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sandoz Felodipine Tablets Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 SHANXI KANGBO BIOLOGICAL PRODUCT
6.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
6.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview
6.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Product Portfolio
6.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
6.4 Changzhou Siyao Pharmaceutical
6.4.1 Changzhou Siyao Pharmaceutical Corporation Information
6.4.2 Changzhou Siyao Pharmaceutical Description and Business Overview
6.4.3 Changzhou Siyao Pharmaceutical Felodipine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changzhou Siyao Pharmaceutical Felodipine Tablets Product Portfolio
6.4.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
6.5 Lianhuan Pharma
6.5.1 Lianhuan Pharma Corporation Information
6.5.2 Lianhuan Pharma Description and Business Overview
6.5.3 Lianhuan Pharma Felodipine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lianhuan Pharma Felodipine Tablets Product Portfolio
6.5.5 Lianhuan Pharma Recent Developments/Updates
6.6 Sihuan Pharma
6.6.1 Sihuan Pharma Corporation Information
6.6.2 Sihuan Pharma Description and Business Overview
6.6.3 Sihuan Pharma Felodipine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sihuan Pharma Felodipine Tablets Product Portfolio
6.6.5 Sihuan Pharma Recent Developments/Updates
6.7 CR Double Crane
6.6.1 CR Double Crane Corporation Information
6.6.2 CR Double Crane Description and Business Overview
6.6.3 CR Double Crane Felodipine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CR Double Crane Felodipine Tablets Product Portfolio
6.7.5 CR Double Crane Recent Developments/Updates
6.8 Xiehe Pharma
6.8.1 Xiehe Pharma Corporation Information
6.8.2 Xiehe Pharma Description and Business Overview
6.8.3 Xiehe Pharma Felodipine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Xiehe Pharma Felodipine Tablets Product Portfolio
6.8.5 Xiehe Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Felodipine Tablets Industry Chain Analysis
7.2 Felodipine Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Felodipine Tablets Production Mode & Process
7.4 Felodipine Tablets Sales and Marketing
7.4.1 Felodipine Tablets Sales Channels
7.4.2 Felodipine Tablets Distributors
7.5 Felodipine Tablets Customers
8 Felodipine Tablets Market Dynamics
8.1 Felodipine Tablets Industry Trends
8.2 Felodipine Tablets Market Drivers
8.3 Felodipine Tablets Market Challenges
8.4 Felodipine Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Felodipine Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Felodipine Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Felodipine Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Felodipine Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Felodipine Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Felodipine Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Felodipine Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Felodipine Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Felodipine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Felodipine Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Felodipine Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Felodipine Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Felodipine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Felodipine Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Felodipine Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Felodipine Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Felodipine Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Felodipine Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Felodipine Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Felodipine Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Felodipine Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Felodipine Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Felodipine Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Felodipine Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Felodipine Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Felodipine Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Felodipine Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Felodipine Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Felodipine Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Felodipine Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Felodipine Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Felodipine Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Felodipine Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Felodipine Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Felodipine Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Felodipine Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Felodipine Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Felodipine Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Felodipine Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Felodipine Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Felodipine Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Felodipine Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Felodipine Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Felodipine Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Felodipine Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Felodipine Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Felodipine Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Felodipine Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Felodipine Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Felodipine Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Felodipine Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Felodipine Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Felodipine Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Felodipine Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Felodipine Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Felodipine Tablets Price (US$/Unit) by Type (2019-2024)
Table 59. Global Felodipine Tablets Price (US$/Unit) by Type (2025-2030)
Table 60. Global Felodipine Tablets Sales (K Units) by Application (2019-2024)
Table 61. Global Felodipine Tablets Sales (K Units) by Application (2025-2030)
Table 62. Global Felodipine Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Felodipine Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Felodipine Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Felodipine Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Felodipine Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Felodipine Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Felodipine Tablets Price (US$/Unit) by Application (2019-2024)
Table 69. Global Felodipine Tablets Price (US$/Unit) by Application (2025-2030)
Table 70. Astrazeneca Corporation Information
Table 71. Astrazeneca Description and Business Overview
Table 72. Astrazeneca Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Astrazeneca Felodipine Tablets Product
Table 74. Astrazeneca Recent Developments/Updates
Table 75. Sandoz Corporation Information
Table 76. Sandoz Description and Business Overview
Table 77. Sandoz Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sandoz Felodipine Tablets Product
Table 79. Sandoz Recent Developments/Updates
Table 80. SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
Table 81. SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview
Table 82. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Product
Table 84. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
Table 85. Changzhou Siyao Pharmaceutical Corporation Information
Table 86. Changzhou Siyao Pharmaceutical Description and Business Overview
Table 87. Changzhou Siyao Pharmaceutical Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Changzhou Siyao Pharmaceutical Felodipine Tablets Product
Table 89. Changzhou Siyao Pharmaceutical Recent Developments/Updates
Table 90. Lianhuan Pharma Corporation Information
Table 91. Lianhuan Pharma Description and Business Overview
Table 92. Lianhuan Pharma Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Lianhuan Pharma Felodipine Tablets Product
Table 94. Lianhuan Pharma Recent Developments/Updates
Table 95. Sihuan Pharma Corporation Information
Table 96. Sihuan Pharma Description and Business Overview
Table 97. Sihuan Pharma Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sihuan Pharma Felodipine Tablets Product
Table 99. Sihuan Pharma Recent Developments/Updates
Table 100. CR Double Crane Corporation Information
Table 101. CR Double Crane Description and Business Overview
Table 102. CR Double Crane Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. CR Double Crane Felodipine Tablets Product
Table 104. CR Double Crane Recent Developments/Updates
Table 105. Xiehe Pharma Corporation Information
Table 106. Xiehe Pharma Description and Business Overview
Table 107. Xiehe Pharma Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Xiehe Pharma Felodipine Tablets Product
Table 109. Xiehe Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Felodipine Tablets Distributors List
Table 113. Felodipine Tablets Customers List
Table 114. Felodipine Tablets Market Trends
Table 115. Felodipine Tablets Market Drivers
Table 116. Felodipine Tablets Market Challenges
Table 117. Felodipine Tablets Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Felodipine Tablets
Figure 2. Global Felodipine Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Felodipine Tablets Market Share by Type in 2023 & 2030
Figure 4. Ordinary Tablet Product Picture
Figure 5. Sustained Release Tablet Product Picture
Figure 6. Global Felodipine Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Felodipine Tablets Market Share by Application in 2023 & 2030
Figure 8. Treat High Blood Pressure
Figure 9. Relieve Angina
Figure 10. Others
Figure 11. Global Felodipine Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Felodipine Tablets Market Size (2019-2030) & (US$ Million)
Figure 13. Global Felodipine Tablets Sales (2019-2030) & (K Units)
Figure 14. Global Felodipine Tablets Average Price (US$/Unit) & (2019-2030)
Figure 15. Felodipine Tablets Report Years Considered
Figure 16. Felodipine Tablets Sales Share by Manufacturers in 2023
Figure 17. Global Felodipine Tablets Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Felodipine Tablets Players: Market Share by Revenue in 2023
Figure 19. Felodipine Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Felodipine Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Felodipine Tablets Sales Market Share by Country (2019-2030)
Figure 22. North America Felodipine Tablets Revenue Market Share by Country (2019-2030)
Figure 23. United States Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Felodipine Tablets Sales Market Share by Country (2019-2030)
Figure 26. Europe Felodipine Tablets Revenue Market Share by Country (2019-2030)
Figure 27. Germany Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Felodipine Tablets Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Felodipine Tablets Revenue Market Share by Region (2019-2030)
Figure 34. China Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Felodipine Tablets Sales Market Share by Country (2019-2030)
Figure 44. Latin America Felodipine Tablets Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Felodipine Tablets Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Felodipine Tablets Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Felodipine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Felodipine Tablets by Type (2019-2030)
Figure 54. Global Revenue Market Share of Felodipine Tablets by Type (2019-2030)
Figure 55. Global Felodipine Tablets Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Felodipine Tablets by Application (2019-2030)
Figure 57. Global Revenue Market Share of Felodipine Tablets by Application (2019-2030)
Figure 58. Global Felodipine Tablets Price (US$/Unit) by Application (2019-2030)
Figure 59. Felodipine Tablets Value Chain
Figure 60. Felodipine Tablets Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
